General Information


DRACP ID  DRACP03863

Peptide Name  

Sequence  GIIKKIIKKIIKK

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C74H143N19O14

Absent amino acids  ACDEFHLMNPQRSTVWY

Common amino acids  IK

Mass  173731

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  6

Net charge  6

Boman Index  -284

Hydrophobicity  24.62

Aliphatic Index  180

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26204061

Title  High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13882

DRACP is developed by Dr.Zheng's team.